Dr. Sheikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste 1014
Houston, TX 77030Phone+1 832-325-7084Fax+1 713-500-0773
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1991 - 1994
Nassau University Medical CenterInternship, Internal Medicine, 1990 - 1991
King Edward Medical UniversityClass of 1987
Certifications & Licensure
TX State Medical License 2009 - 2027
MD State Medical License 1994 - 2011
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
- A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS) Start of enrollment: 2022 Nov 01
Publications & Presentations
PubMed
- Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.Robin C M Thomma, Susan K Halstead, Laura C de Koning, Evelin E J A Wiegers, Dawn S Gourlay
Brain. 2025-03-17 - Tumor necrosis factor α receptor 1A transduces the inhibitory effect on axon regeneration triggered by IgG anti-ganglioside GD1a antibodies.Bárbara B Báez, Cristian R Bacaglio, Jillian M Prendergast, Victoria Rozés-Salvador, Kazim A Sheikh
Biochimica Et Biophysica Acta. Molecular Basis of Disease. 2024-10-01 - A National Cross-Sectional Survey of EMG Physician Volume.Thy P Nguyen, Deepa Dongarwar, Rajesh K Gupta, Suur Biliciler, Kazim A Sheikh
Neurology. Clinical Practice. 2024-10-01
Press Mentions
The Patient’s Wife Thought Her Husband Was Being Treated for the Wrong Disease. She Was RightFebruary 1st, 2019
Grant Support
- Modulation of CSF1R Signaling to Treat Inflammatory NeuropathiesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2028
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
